Are there any drug interactions between tizanidine and famotidine (Pepcid)?

Yes, there is a clinically significant drug interaction between tizanidine and famotidine (Pepcid)

Famotidine can cause significant hypotension, bradycardia, and sedation when combined with tizanidine, as famotidine is a CYP1A2 inhibitor that reduces tizanidine clearance. 1

Mechanism of Interaction

Tizanidine is primarily metabolized by the CYP1A2 enzyme system. Famotidine acts as a CYP1A2 inhibitor, which significantly impairs tizanidine metabolism and leads to elevated plasma concentrations 1. This pharmacokinetic interaction results in:

• Increased tizanidine exposure with prolonged drug effects
• Enhanced adverse effects, particularly cardiovascular complications
• Accumulation risk with repeated dosing

Clinical Consequences

The 2021 SPAQI consensus guidelines explicitly list famotidine among CYP1A2 inhibitors that can cause significant hypotension, bradycardia, and sedation when given with tizanidine 1.

Real-world evidence supports this concern:

• A case report documented acute severe cystitis in a patient taking both tizanidine and famotidine 2
• Disproportionality analysis of FDA adverse event data showed elevated reporting of hypotension, syncope, falls, and cardiovascular events with tizanidine-CYP1A2 inhibitor combinations 3

Risk Stratification

Higher risk patients include:

• Those with hepatic dysfunction (tizanidine clearance already compromised)
• Elderly patients (baseline 4-fold decreased clearance) 4
• Patients with renal insufficiency (>50% reduction in clearance) 4
• Those on other CNS depressants or antihypertensives

Clinical Management Recommendations

If this combination cannot be avoided:

1. Reduce tizanidine dose - Start with lower individual doses rather than reducing frequency 4
2. Monitor closely for:
   • Orthostatic hypotension (check supine and standing blood pressures)
   • Excessive sedation or drowsiness
   • Bradycardia
   • Dizziness or syncope
3. Counsel patients about fall risk and avoiding activities requiring alertness 4

Preferred alternatives:

• Consider alternative H2-blockers or proton pump inhibitors that don't inhibit CYP1A2 as significantly
• If acid suppression is needed, omeprazole has been studied with tizanidine without requiring dose adjustment 5, 6, 5, 6

Important Caveats

While famotidine is listed as a CYP1A2 inhibitor of concern, it is less potent than ciprofloxacin or fluvoxamine (which are absolutely contraindicated with tizanidine) 1. However, the interaction remains clinically significant enough to warrant caution and monitoring, particularly given the potential for serious cardiovascular adverse events including hypotension and syncope that can lead to falls and fractures 3, 7.

The combination should be used with extreme caution, not routinely avoided, but requires dose reduction of tizanidine and close monitoring for cardiovascular adverse effects.